Skip to search formSkip to main contentSkip to account menu

Liposomal Bupivacaine

Known as: Bupivacaine Liposome Injectable Suspension 
A liposome-encapsulated formulation of bupivacaine, which is an amide-type, long-acting local anesthetic. Upon administration, bupivacaine reversibly… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Fascia iliaca blockade with the addition of liposomal bupivacaine vs. plain bupivacaine for perioperative pain management following hip arthroscopy
PurposeA newer formulation of bupivacaine, encapsulated within carrier molecules, has garnered attention for its role in… 
2018
2018
Medication, equipment, and supply costs for common interventions providing extended post-surgical analgesia following total knee arthroplasty in US hospitals
Abstract Aims: To estimate the cost to hospitals of materials (i.e. medications, equipment, and supplies) required to administer… 
2016
2016
Liposomal Bupivacaine for Pain Control After Anterior Cruciate Ligament Reconstruction
Background: Local anesthetics are commonly administered into surgical sites as a part of multimodal pain control regimens… 
Review
2016
Review
2016
Effects of Liposomal Bupivacaine With Adductor Canal Block on Pain and Functional Outcomes in Patients Undergoing Total Knee Arthroplasty
Background: Liposomal bupivacaine (LB) has an extended duration of action compared to bupivacaine and may allow patients to reach… 
2015
2015
A Randomized Controlled Trial for Pain Control in Laparoscopic Urologic Surgery: 0.25% Bupivacaine Versus Long-Acting Liposomal Bupivacaine.
Abstract Background and Purpose: Liposomal bupivacaine is a delayed-release preparation providing up to 72 hours of local… 
2015
2015
Neurotoxicity of perineural vs intraneural–extrafascicular injection of liposomal bupivacaine in the porcine model of sciatic nerve block†
Liposomal bupivacaine is a prolonged‐release local anaesthetic, the neurotoxicity of which has not yet been determined. We used… 
2015
2015
Comparison Between Liposomal Bupivacaine and Femoral Nerve Block in Patients Undergoing Primary Total Knee Arthroplasty.
This study sought to evaluate opioid consumption, hospitalization costs, and length of stay when surgical site periarticular… 
2015
2015
Liposomal bupivacaine versus continuous infusion bupivacaine via an elastomeric pump for the treatment of postoperative pain.
PURPOSE The duration of analgesia and comparative efficacy of liposomal bupivacaine and an elastomeric bupivacaine pump in a… 
Review
2015
Review
2015
Use of Liposomal Bupivacaine Instead of an Epidural Can Improve Outcomes Following Total Knee Arthroplasty.
The purpose of this study was to compare periarticular injection of liposomal bupivacaine (LB) to epidural analgesia as part of… 
1995
1995
Motor blockade and absence of local nerve toxicity induced by liposomal bupivacaine injected into the brachial plexus of rabbits.
Bupivacaine has been encapsulated into multilameller liposomes in order to reduce its systemic toxicity and to lengthen its… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)